What is ACONW's market cap?

$51.20K, based on the Sep 28 close of $0.03.

What sector is ACONW in?

Healthcare, in the Medical Labs industry.

NASDAQ · ACONWHealthcareMedical Labs

Aclarion, Inc. Warrant (ACONW)

$0.0256−0.39%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$0.03▼ 34.02% in range

Sep 29, 2025Low $0.02 · High $0.10Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Aclarion, Inc. Warrant closed at $0.03 on Sep 28, down 0.39%, 75.2% below its highest close since Apr 22. Volume of 60.8K shares was 8.12× its 20-day average (well above normal).

Split-adjusted performance: -19.2% over one month, -36.8% over six months.

In the quarter ended Jun 30, 2026, revenue was $25.21K, up 30.5% from a year earlier, with a net margin of -10899.5%.

Short interest was 66.3K shares at the Sep 15 settlement, down 5.1% from the prior report (27.1 days to cover).

Market cap$51.2K2.0M shares

Revenue · quarter$25.2K+30.5% YoY

Diluted EPS$-1.12—

P/E · TTM—P/S 0.6×

Net margin-10,899.5%Gross 32.9%

Dividend yieldNone

Range since Apr 220.02 – 0.10−75.2% from high

Volume60.8K8.12× 20-day avg

Volatility · 60d223.1%Annualised

Short % of float—27.1 days to cover

Net cash$16.3MCash $16.3M

Next earnings—Not scheduled

Split-adjusted performance

1W −8.6%1M −19.2%3M −8.2%6M −36.8%YTD −32.5%1Y —3Y −81.7%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Medical Labs

Percentile among 24 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return +52.7%, revenue growth +25.0%, net margin −6.1%, P/E 27.6×.

Short interest

Details →

Shares short66.3K−5.1% vs prior

Days to cover27.1Settled Sep 15

% of float—

Short vol. 10d100.0%of daily volume

News about Aclarion, Inc. Warrant

All news →

No recent articles focused on Aclarion, Inc. Warrant. 6 articles mention it in passing.

Quick answers

What does Aclarion, Inc. Warrant do?: Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan.
What is ACONW's market cap?: $51.20K, based on the Sep 28 close of $0.03.
What sector is ACONW in?: Healthcare, in the Medical Labs industry.

About Aclarion, Inc. Warrant

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

HQ: Broomfield, CO11 employeesListed Apr 22, 2022aclarion.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology